Flashback and Hallucinogen Persisting Perception Disorder: clinical aspects and pharmacological treatment approach. January 1, 2002
No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography Study February 1, 2001
DMT: The Spirit Molecule – A Doctor's Revolutionary Research into the Biology of Near-Death and Mystical Experiences December 1, 2000
LSD-induced hallucinogen persisting perception disorder treatment with clonidine: an open pilot study. January 1, 2000
Do entheogen-induced mystical experiences boost the immune system? Psychedelics, peak experiences, and wellness January 1, 1999
Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action December 1, 1998
